R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins. It’s the first part of what the company describes will grow to become a ...
Siemens AG—and that’s Siemens Siemens, not Siemens Healthineers—is expanding its industrial software business further into the life sciences, with a $5.1 billion plan to acquire digital R&D platform ...
The primary focus of the 7.1 release is a significant overhaul of the UI and user experience (UX). After close collaboration with customers, Dotmatics simplified the navigation across and within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results